Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Gross Margin (2016 - 2026)

Conmed filings provide 17 years of Gross Margin readings, the most recent being 57.86% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 253.0% to 57.86% in Q1 2026 year-over-year; TTM through Mar 2026 was 55.17%, a 97.0% decrease, with the full-year FY2025 number at 54.59%, down 149.0% from a year prior.
  • Gross Margin hit 57.86% in Q1 2026 for Conmed, down from 58.49% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 58.49% in Q4 2025 to a low of 49.16% in Q3 2025.
  • Median Gross Margin over the past 5 years was 55.18% (2023), compared with a mean of 55.05%.
  • Biggest five-year swings in Gross Margin: skyrocketed 314bps in 2023 and later tumbled -736bps in 2025.
  • Conmed's Gross Margin stood at 52.56% in 2022, then grew by 6bps to 55.7% in 2023, then increased by 3bps to 57.33% in 2024, then rose by 2bps to 58.49% in 2025, then dropped by -1bps to 57.86% in 2026.
  • The last three reported values for Gross Margin were 57.86% (Q1 2026), 58.49% (Q4 2025), and 49.16% (Q3 2025) per Business Quant data.